logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
PE/iFluor® 700 Anti-human CD138 Antibody
MI15
The MI15 monoclonal antibody reacts with human CD138, a 100 - 200 kD transmembrane protein typically expressed on the surface of b cells, plasma cells, epithelial cells and endothelial cells. CD138 is involved with important cellular pathways, in particular, the cytokine-mediated signaling pathway and canonical Wnt signaling pathway. Also, in certain organisms, it enhances extracellular exosome assembly and is a promoter of exosomal secretion. From a research standpoint, it is of biological interest due to its association with critical macromolecules/ligands such as Fibronectin. CD138 is a fairly uncommon antibody target, with a little more than 7000 publications in the last decade. Even still, CD138 is frequently used in flow cytometry applications as a phenotypic marker for differentiation of cell types, specifically in the study of cell motility/cytoskeleton/structure, cell biology and synaptic biology. This antibody was purified through affinity chromatography and conjugated to PE/iFluor® 700 (ex/em = 566/708 nm). It is compatible with the 561 nm laser and 695/40 nm bandpass filter (for example, as in the Agilent Technologies NovoCyte Advanteon).
product image
product image
CatalogSize
Price
Quantity
113801X025 tests
Price
113801X1100 tests
Price
113801X2500 tests
Price
 
Antibody properties

Other namesSyndecan-1
CloneMI15
Hostmouse
Isotypemouse IgG1
Reactivityhuman
Spectral properties

Absorbance (nm)566
Extinction coefficient (cm -1 M -1)
1960000
Excitation (nm)565
Emission (nm)708
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 7, 2025